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We show high rates of extended-spectrum β-lactamase–
producing Enterobacteriaceae carriage among the staff and 
children at an orphanage in Bamako, Mali. Enterobacteri-
aceae colonized in 100% and 63%, respectively, of the 38 
children and 30 adults studied. Use of antimicrobial drugs 
appeared excessive and inappropriate; decontamination 
and hygiene protocols were also questioned.
E
xtended-spectrum β-lactamase (ESBL)–producing En-
terobacteriaceae pose a major health problem because 
the incidence rate of infection is particularly high (1–3), 
and delays in the prescription of appropriate antimicrobial 
drug therapy for these infections are a risk factor for poor 
prognosis and death (4). In the 36 months preceding our 
study, children adopted by French families, and who were 
followed up at the Brest University Hospital, were shown 
to be carriers of ESBL-producing Enterobacteriaceae. 
All of these children had resided at the state orphanage in 
Bamako, Mali.
The dominant, and consequently widespread, mani-
festation of ESBL-producing Enterobacteriaceae in these 
children was the catalyst for our prospective investigation. 
We studied the carriage rate of these bacteria for the chil-
dren and personnel of the orphanage and also the living 
conditions within the orphanage.
The Study
This prospective cross-sectional study was conducted 
during September 10–19, 2003. The study population in-
cluded 44 staff members and 39 children who were residing 
in the orphanage on the day the bacteriologic samples were 
taken. Adults were included on a voluntary basis and gave 
informed consent. Informed consent for the children was 
obtained from their legal representative, the director of the 
orphanage. Anonymity of participants was guaranteed.
We examined clinical data from charts as well as life-
style habits, including personal and environmental hygiene. 
Environmental samples and children’s stool samples were 
obtained. Adults obtained their own stool samples. Envi-
ronmental samples comprised potable tap water (1 sample) 
and surface samples (2 silicone bottle nipples, 1 child toilet, 
2 faucets, and 1 sink that served as both a dishwashing and 
child-bathing station).
Samples were stored at 4°C and were sent by air within 
18 hours to the microbiology laboratory of Brest University 
Hospital for analysis. Immediately upon arrival, the sam-
ples were injected into a Drigalski medium (bioMérieux, 
Marcy l’Etoile, France) supplemented with ceftazidime at 
2 mg/L. This medium allows for selective isolation of re-
sistant gram-negative bacteria. Colonies that developed on 
this medium showed different shapes and were systemati-
cally identiﬁ  ed by using the API20E system (bioMérieux). 
Antimicrobial-drug susceptibility patterns were determined 
by the disk-diffusion method, as deﬁ  ned by the Committee 
for Antimicrobial Susceptibility Testing of the French Soci-
ety for Microbiology (5). Enterobacteriaceae were consid-
ered ESBL producers if synergy between third-generation 
cephalosporins and amoxicillin associated with clavulanic 
acid was detected (5,6).
Of the 30 adults sampled, 19 (63%) were found to be 
colonized with 1–3 ESBL-producing Enterobacteriaceae 
of the same or different species (9 samples showed 1 strain; 
7 showed 2 strains, and 3 showed 3 strains). More carriers 
were found in the caregiver adult group, who had direct con-
tact with the children, than in those with less interactive re-
sponsibilities (e.g., administration and housekeeping staff), 
90% (16/18) versus 25% (3/12), respectively (p<0.0016).
We included 38 of the 39 children in the analysis; no 
stool sample was available for the remaining child. All 
children sampled carried 1–3 ESBL-producing Enterobac-
teriaceae (21 with 2 strains and 9 with 3 strains). Bacteria 
samples from children were colonized more often than that 
of adults with >1 ESBL-producing Enterobacteriaceae, 
78% (30/38) and 52% (10/19), respectively (p = 0.04). 
Water samples collected contained no ESBL-producing 
Enterobacteriaceae. The other 6 environmental samples 
testing positive showed 1 (4 samples), 2 (1 sample), or 3 (1 
sample) strains of ESBL-producing Enterobacteriaceae.
We isolated 118 strains of ESBL-producing Enterobac-
teriaceae: Escherichia coli (56%), Klebsiella pneumoniae 
(36%), K. oxytoca (4%), and Citrobacter freundii (4%). De-
pending on the species, 36%–79% of strains were resistant 
to aminoglycosides, 20%–50% were resistant to ﬂ  uoroqui-
nolones, and >94% were resistant to cotrimoxazole.
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Clonal relatedness of the 52 E. coli ESBL-producing 
strains was assessed by pulsed-ﬁ   eld gel electrophoresis 
(Figure). Among these, 12 unique subtypes and 15 clusters 
of 2–7 clonal strains were identiﬁ  ed. Dissemination might 
follow an allodemic pattern, corresponding to the spread of 
multiple speciﬁ  c clones or genetic elements. 
The high colonization rate for caregiver adults within 
our study (90%) could logically and predominantly be attrib-
uted to direct contamination from the children. Furthermore, 
the excessive use of antimicrobial drugs also contributes to 
the emergence and spread of multidrug-resistant bacteria, as 
previously stated by Harbarth and van de Sande-Bruinsma 
(7,8). The health records of the 39 children showed that 88 
courses of antimicrobial drugs had been prescribed to 27 
children during their stay at the orphanage during the 1,921 
weeks that the children lived in the orphanage. Many of the 
antimicrobial drugs prescribed at the orphanage were used 
for infections of unlikely bacterial etiology. Many authors 
have emphasized that the inappropriate use of antimicrobial 
drugs, particularly among the children of various nonindus-
trialized nations, leads to antimicrobial resistance (9,10). 
However, this phenomenon also exists in developing nations 
(11). The antimicrobial drugs most frequently prescribed 
were third-generation cephalosporins and penicillins, which 
according to Colodner, favor the carriage of ESBL-produc-
ing Enterobacteriaceae (12). The dosages prescribed were 
not always adapted to the precise weight of the children, 
thereby favoring the development of resistance. In addition, 
the duration of antimicrobial drug therapy, which also fa-
vors the development of resistance, was often limited for 
economic reasons, (13,14). 
We also suggest that dissemination of ESBL-produc-
ing  Enterobacteriaceae  within the orphanage might be 
explained by close contact between persons and massive 
contamination of the environment. With the exception of 
the water supply, all environmental samples tested positive 
despite compliance with posted hygiene rules and the best 
efforts and intentions of personnel. Feeding bottles were 
prepared on a bench top next to the sink, which was also 
used for bathing infants, and this sink was not regularly de-
contaminated during the day. Water was served in 1 shared 
drinking cup. Moreover, traditions such as eating from a 
shared plate and washing only 1 hand, along with a lack 
of material and ﬁ  nancial means, appeared to clearly favor 
ESBL-producing  Enterobacteriaceae colonization in the 
children. Childcare personnel washed their hands with soap 
and a diluted bleach solution before and after each caregiv-
ing interaction. Taps were operated manually without any 
particular contamination precautions. These environmental 
hygiene conditions contributed to the dissemination of the 
multidrug-resistant strains of Enterobacteriaceae.
Although this study gives a precise idea of the situation 
at the orphanage, our study has limitations. 1) The kinetics 
of colonization within the orphanage remain unknown; 2) 
the lack of a control group without ESBLs does not allow 
a comparison of the antimicrobial drug use; and 3) the rate 
of ESBL-producing Enterobacteriaceae carriage overall in 
Malian children of similar age and sex has not been scien-
tiﬁ  cally determined.
Conclusions
This study provides evidence that the carriage of 
ESBL-producing Enterobacteriaceae is prevalent at the or-
phanage in Bamako; dissemination is widespread among 
children and staff and within the environment. We iden-
tiﬁ  ed 2 key factors responsible for this type of epidemic: 
1) inadequate hygiene conditions favoring the spread of 
ESBL-producing Enterobacteriaceae in the environment 
and 2) the qualitative and quantitative inappropriate use 
of antimicrobial drugs. We therefore strongly recommend 
implementation of appropriate hygiene practices to limit 
colonization. Of equal importance is the coupling of these 
measures with a targeted and reasonable approach to the 
use of antimicrobial drugs.
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Figure. Representative XbaI pulsed-ﬁ  eld gel electrophoresis proﬁ  les 
of extended-spectrum β-lactamase–producing  Escherichia coli. 
Isolates denoted A originate from adults, P from children <4 months 
of age, M from children 4–12 months of age, G from children >12 
months of age, and E and R from environmental samples.Our results raise questions about the importance of 
quickly and accurately identifying persons who carry 
ESBL-producing Enterobacteriaceae because initiation of 
appropriate antimicrobial drug therapy may be delayed for 
infected patients and infection could spread rapidly. Test-
ing for ESBL-producing Enterobacteriaceae in stools ap-
pears to be justiﬁ  ed as part of the initial examination of 
all adopted children who have lived in an institution where 
these microorganisms are endemic.
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